Orasure Technologies Inc: Mariko Gordon’s Daruma Capital Management Llc Bought Stake

February 15, 2018 - By Marie Mckinney

 Orasure Technologies Inc: Mariko Gordon's Daruma Capital Management Llc Bought Stake

Investors sentiment decreased to 1.01 in 2017 Q3. Its down 0.15, from 1.16 in 2017Q2. It worsened, as 18 investors sold OraSure Technologies, Inc. shares while 69 reduced holdings. 35 funds opened positions while 53 raised stakes. 54.93 million shares or 2.92% more from 53.38 million shares in 2017Q2 were reported.

Wells Fargo And Mn accumulated 614,821 shares or 0% of the stock. Teachers Retirement Of The State Of Kentucky accumulated 0.01% or 19,400 shares. Pub Employees Retirement Association Of Colorado reported 20,172 shares. 864,258 were accumulated by Millennium Ltd Liability. Pier Capital Limited Liability holds 258,630 shares. Panagora Asset has invested 0.03% in OraSure Technologies, Inc. (NASDAQ:OSUR). Strs Ohio holds 0% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR) for 42,700 shares. 43,408 were accumulated by Texas Permanent School Fund. Alliancebernstein Limited Partnership stated it has 0% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). Argyle Capital stated it has 18,025 shares. Hanseatic Management Svcs owns 172 shares or 0% of their US portfolio. Hanson Mcclain Inc owns 800 shares. Clarivest Asset Mgmt Ltd Liability, California-based fund reported 266,122 shares. Glenmede Company Na holds 25,336 shares or 0% of its portfolio. Campbell & Investment Adviser Limited Liability Company invested 0.27% in OraSure Technologies, Inc. (NASDAQ:OSUR).

Since August 22, 2017, it had 0 insider purchases, and 5 sales for $1.36 million activity. $186,516 worth of OraSure Technologies, Inc. (NASDAQ:OSUR) was sold by SMITH BRIAN. 1,000 shares valued at $20,110 were sold by Patrick Charles W on Wednesday, August 30.

The New Mariko Gordon’s Daruma Capital Management Llc Holding in Orasure Technologies Inc

Daruma Capital Management Llc reported SC 13G form with the SEC for Orasure Technologies Inc. Access it here: 000108514618000833. As reported by Mariko Gordon’s Daruma Capital Management Llc, the filler owns 5.01% or 3,038,215 shares of the Health Care–company.

Orasure Technologies Inc stake is new for [reportingPerson]. Date of activity: December 31, 2017. This shows Mariko Gordon’s Daruma Capital Management Llc’s positive view for Orasure Technologies Inc. For a hedge fund managing $2.31 billion in assets and having 20+ experts this is interesting position.

The hedge fund is investor in the Health Care sector. In the manager’s last 13-F, we saw 12% of Mariko Gordon’s Daruma Capital Management Llc’s portfolio is in the sector.

Orasure Technologies Inc Institutional Sentiment

Filings show 133 investors own Orasure Technologies Inc. The ownership in Q3 2015 is high, at 60.69 % of the outstanding shares. This is increased by 898003. 36798761 were owned by these investors. 18 funds opened new Orasure Technologies Inc stakes, 49 increased positions. There were 9 that closed positions and 43 reduced them.

Leighton Welch Welch Capital Partners Llc is an investor bullish on Orasure Technologies Inc, owning 69760 shares as of Q3 2015 for 0.11% of its portfolio. Stephen Dubois Camber Capital Management Llc owns 2000000 shares or 0.76% of its portfolio. V7 Healthinvest Partners Ab have 0.73% of its portfolio for 276603 shares. Further, Rtw Investments Llc reported stake worth 0.45% of its portfolio. The NY Domini Social Investments Llc owns 107254 shares. Orasure Technologies Inc is 7.78% of its portfolio.

Business Profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.

SEC Form 13G.

Mariko Gordon’s Daruma Capital Management Llc website.

The stock increased 1.51% or $0.27 during the last trading session, reaching $18.13. About 273,332 shares traded. OraSure Technologies, Inc. (NASDAQ:OSUR) has risen 116.07% since February 15, 2017 and is uptrending. It has outperformed by 99.37% the S&P500.

OraSure Technologies, Inc., together with its subsidiaries, develops, makes, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company has market cap of $1.10 billion. It operates in two divisions, OSUR and DNAG. It has a 34.93 P/E ratio. The firm also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

OraSure Technologies, Inc. (NASDAQ:OSUR) Ratings Coverage

Among 6 analysts covering OraSure Technologies (NASDAQ:OSUR), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. OraSure Technologies has $24.0 highest and $8 lowest target. $15.13’s average target is -16.55% below currents $18.13 stock price. OraSure Technologies had 25 analyst reports since August 6, 2015 according to SRatingsIntel. As per Thursday, August 4, the company rating was maintained by Jefferies. The firm has “Buy” rating by Jefferies given on Friday, October 20. The stock of OraSure Technologies, Inc. (NASDAQ:OSUR) earned “Hold” rating by Jefferies on Thursday, November 2. The stock has “Buy” rating by Mizuho on Thursday, November 5. The firm earned “Buy” rating on Thursday, June 8 by Jefferies. The stock has “Outperform” rating by Raymond James on Thursday, February 9. The company was downgraded on Monday, June 13 by Raymond James. Jefferies maintained OraSure Technologies, Inc. (NASDAQ:OSUR) on Thursday, August 3 with “Buy” rating. The firm has “Buy” rating given on Friday, February 2 by Canaccord Genuity. Canaccord Genuity maintained it with “Buy” rating and $22.0 target in Monday, October 23 report.

More news for OraSure Technologies, Inc. (NASDAQ:OSUR) were recently published by: Globenewswire.com, which released: “OraSure Technologies Appoints Aradhana Sarin, MD to Board of Directors” on February 02, 2018. Globenewswire.com‘s article titled: “OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare …” and published on February 08, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.